295 results on '"Tomiya, Tomoaki"'
Search Results
2. NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir
3. A case of colonic varices complicated by alcoholic cirrhosis treated using balloon-occluded retrograde transvenous obliteration
4. Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir
5. Portal venous blood flows determine liver function in patients with decompensated cirrhosis due to HCV infection receiving successful sofosbuvir/velpatasvir therapy
6. Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct‐acting antivirals
7. Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis
8. Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices
9. Significance of the Relation Between Hepatocyte Growth Factor and Transforming Growth Factor-α in Hepatocyte Proliferation
10. Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog
11. Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation
12. Evaluation of the Validity of SARS-CoV-2 Infection Control Measures through Antibody Testing for Employees of a University and Hospital
13. Autotaxin as a novel serum marker of liver fibrosis
14. Expression of α-taxilin in the murine gastrointestinal tract: potential implication in cell proliferation
15. Treatment for minimal hepatic encephalopathy: Are we ghost busters?
16. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential
17. Expression of Transforming Growth Factor-α and -β in Hepatic Lobes After Hemihepatic Portal Vein Embolization
18. Rho-kinase inhibitor prevents hepatocyte damage in acute liver injury induced by carbon tetrachloride in rats
19. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity
20. Balloon‐occluded retrograde transvenous obliteration as a procedure to improve liver function in patients with decompensated cirrhosis
21. Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis
22. Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis
23. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells
24. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents
25. Reduction of collagen production by insulin-like growth factor I is independent of modulation of activation state in hepatic stellate cells: 1235
26. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate
27. Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome
28. Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus
29. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate
30. Sex difference in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
31. Transforming growth factor-alpha (TGF α)-producing gastric carcinoma with acanthosis nigricans: An endocrine effect of TGF α in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus
32. Impaired liver regeneration in acute liver failure: the significance of cross-communication of growth associated factors in liver regeneration
33. Ischemic preconditioning in liver pathophysiology
34. Use of prostaglandin I2 analog in treatment of massive hepatic necrosis associated with endothelial cell injury and diffuse sinusoidal fibrin deposition
35. The herbal medicine inchin-ko-to (TJ-135) induces apoptosis in cultured rat hepatic stellate cells
36. Regulating factors of liver regeneration after hepatectomy
37. Abstracts of selected papers presented at the 79th general meeting of the Japanese Society of Gastroenterology March 29–31, 1993, Kyoto, Japan
38. Abstracts of selected papers presented at the 33rd Annual Meeting of the Japanese Society of Gastroenterology
39. Abstracts of selected papers presented at the 32nd Annual Meeting of the Japanese Society of Gastroenterology
40. A case of genotype‐3b hepatitis C virus in which the whole genome was successfully analyzed using third‐generation nanopore sequencing
41. Deteriorated outcome of recent patients with acute liver failure and late‐onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan
42. Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy
43. Enhancement of albumin production by hepatocyte growth factor in rat hepatocytes: distinction in mode of action from stimulation of DNA synthesis
44. Circulating immune complex of hepatitis virus C in patients with acute and chronic hepatitis C
45. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis
46. Plasma thrombin-antithrombin III complexes in the diagnosis of primary hepatocellular carcinoma complicating liver cirrhosis
47. Experimental study on liver regeneration after simultaneous partial hepatectomy and pancreatectomy
48. Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy
49. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan
50. Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct‐acting antivirals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.